Top Story

CTR-blocked angle increases IOP in chronic hypotony

April 25, 2019

Rocklatan approval tops recent glaucoma news

April 22, 2019
The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on in…

Netarsudil phase 2 trial begins in Japan

March 28, 2019
Aerie Pharmaceuticals has initiated dosing in a phase 2 clinical trial of netarsudil ophthalmic solution in Japan, according to a press release. In accordance with…
Meeting News

Machine-to-machine learning may lead to improved grading of disc photos

March 27, 2019
SAN FRANCISCO — A machine-to-machine method of deep learning may lead to a more accurate way to estimate the presence of glaucoma from photographs, according to a…
More Headlines »
Clinical Science

Multifocal Visual Evoked Potentials for Early Glaucoma Detection

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To compare multifocal visual evoked potentials (mfVEP) with other detection methods in early open-angle glaucoma. Ten…
More »

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently…
More »
Meeting News

VIDEO: Phase 2 data show IOP reduction for 1 year with iDose

February 12, 2019
More »